Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Miller

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathwaySathit Pichyangkul, Kosol Yongvanitchit, Utaiwan Kum-arb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge modelGregory A Deye, R Scott Miller, Lori Miller, et al.
The American Journal of Tropical Medicine and Hygiene|May 25, 2004
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysDouglas S Walsh, Sathit Pichyangkul, Montip Gettayacamin, et al.
Vaccine|September 15, 2004
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alumSathit Pichyangkul, Montip Gettayacamin, R Scott Miller, et al.
JAMA Internal Medicine|November 18, 2014
Effects of hyperbaric oxygen on symptoms and quality of life among service members with persistent postconcussion symptoms: a randomized clinical trialR Scott Miller, Lindell K Weaver, Nazanin Bahraini, et al.
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
The Journal of Infectious Diseases|December 20, 2011
A simplified intravenous artesunate regimen for severe malariaPeter Gottfried Kremsner, Terrie Taylor, Saadou Issifou, et al.
Journal of Clinical Microbiology|June 7, 2003
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigenJ Russ Forney, Chansuda Wongsrichanalai, Alan J Magill, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathwaySathit Pichyangkul, Kosol Yongvanitchit, Utaiwan Kum-arb, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge modelGregory A Deye, R Scott Miller, Lori Miller, et al.
The American Journal of Tropical Medicine and Hygiene|May 25, 2004
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysDouglas S Walsh, Sathit Pichyangkul, Montip Gettayacamin, et al.
Vaccine|September 15, 2004
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alumSathit Pichyangkul, Montip Gettayacamin, R Scott Miller, et al.
JAMA Internal Medicine|November 18, 2014
Effects of hyperbaric oxygen on symptoms and quality of life among service members with persistent postconcussion symptoms: a randomized clinical trialR Scott Miller, Lindell K Weaver, Nazanin Bahraini, et al.
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
The Journal of Infectious Diseases|December 20, 2011
A simplified intravenous artesunate regimen for severe malariaPeter Gottfried Kremsner, Terrie Taylor, Saadou Issifou, et al.
Journal of Clinical Microbiology|June 7, 2003
Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigenJ Russ Forney, Chansuda Wongsrichanalai, Alan J Magill, et al.
Pageof 5